Phagothérapie pour traiter les infections respiratoires [Phage therapy for respiratory infections]
Details
Download: RMS_804_2150.pdf (185.29 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_CCFF1CBAD0AE
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Phagothérapie pour traiter les infections respiratoires [Phage therapy for respiratory infections]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
16/11/2022
Peer-reviewed
Oui
Volume
18
Number
804
Pages
2150-2156
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
The crisis of antibiotic resistance represents a global public health challenge, affecting particularly patients with respiratory infections. The use of (bacterio)phages for the treatment of bacterial infections (phage therapy) seems safe but its effectiveness has not yet been proven by controlled clinical trials. Nevertheless, phage therapy is regaining interest, encouraged by published cases treated successfully with personalized phage combinations as well as significant advances at a preclinical level. Standardized approaches in phage production and treatment administration, as well as future translational studies, are needed to improve our understanding and explore the potential of phage therapy.
Keywords
Humans, Phage Therapy, Bacterial Infections/therapy, Bacterial Infections/microbiology, Bacteriophages, Respiratory Tract Infections/therapy, Drug Resistance, Microbial, Anti-Bacterial Agents/therapeutic use, Anti-Bacterial Agents/pharmacology
Pubmed
Create date
29/11/2022 11:49
Last modification date
11/08/2023 7:16